Clinical Edge Journal Scan

Sarcopenia index significantly linked to subclinical atherosclerosis prevalence in T2D


 

Key clinical point : The sarcopenia index (SI; serum creatinine/serum cystatin C ratio) is significantly associated with the prevalence of subclinical atherosclerosis in patients with type 2 diabetes mellitus (T2D).

Major finding: After adjusting for all confounders, SI was significantly associated with the prevalence of subclinical atherosclerosis (adjusted odds ratio 0.95; P = .015).

Study details: The data come from a cross-sectional study of 174 patients with T2D, of which 43.7% were diagnosed with subclinical atherosclerosis.

Disclosures: The study received no specific funding. Some authors declared receiving honoraria, personal fees, r research grants from various sources.

Source: Hashimoto Y et al. Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2022;10:e002910 (Jun 23). Doi: 10.1136/bmjdrc-2022-002910

Recommended Reading

Medicare advantage tied to less use of pricey diabetes drugs
Type 2 Diabetes ICYMI
Remnant cholesterol captures residual CV risk in patients with T2D
Type 2 Diabetes ICYMI
T2D: Significant improvement in glycemic control with efpeglenatide
Type 2 Diabetes ICYMI
Semaglutide improves glycemic control in patients with prediabetes
Type 2 Diabetes ICYMI
SGLT2i vs GLP-1RA or DPP4i lowers the risk for new-onset AF in T2D
Type 2 Diabetes ICYMI
DPP4 inhibitor ups risk for cholecystitis in T2D
Type 2 Diabetes ICYMI
Initiating semaglutide improves outcomes in patients on high daily doses of insulin
Type 2 Diabetes ICYMI
Prusogliptin add-on to metformin safe and effective in T2D
Type 2 Diabetes ICYMI
SGLT2i vs DPP4i lowers death risk in T2D
Type 2 Diabetes ICYMI
Real-world insights of initiating or switching to insulin degludec/aspart in T2D
Type 2 Diabetes ICYMI